Pàgina inicial > Resultats de la cerca: Ziemssen, Tjalf
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 4 registres trobats en 0.01 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
8 p, 1.1 MB Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis : Benefit/risk following review of trial and post-marketing data / Coles, Alasdair J. (University of Cambridge) ; Jones, Joanne L. (University of Cambridge) ; Vermersch, Patrick (Université de Lille) ; Traboulsee, Anthony (University of British Columbia) ; Bass, Ann D. (Neurology Center of San Antonio) ; Boster, Aaron (Boster Center for Multiple Sclerosis) ; Chan, Andrew (University of Bern) ; Comi, Giancarlo (Vita-Salute San Raffaele University) ; Fernández, Óscar (Hospital Regional Universitario Carlos Haya (Málaga)) ; Giovannoni, Gavin (Queen Mary University of London) ; Kubala Havrdova, Eva (Charles University) ; LaGanke, Christopher (North Central Neurology Associates) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Oreja-Guevara, Celia (Universidad Complutense de Madrid) ; Piehl, Fredrik (Karolinska Institutet (Estocolm, Suècia)) ; Wiendl, Heinz (University of Münster) ; Ziemssen, Tjalf (Dresden University of Technology) ; Universitat Autònoma de Barcelona
Does preexisting or treatment-emergent autoimmunity increase the risk of subsequent autoimmune disease in individuals with relapsing-remitting multiple sclerosis (MS) after alemtuzumab? In the extended phase 2/3 trials, 34/96 (35. [...]
2022 - 10.1177/13524585211061335
Multiple sclerosis, Vol. 28 Núm. 5 (2022) , p. 842-846  
Registre complet - Creative Commons
2.
7 p, 813.8 KB Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions / Cohen, Jeffrey A. (Mellen Center, Neurologic Institute, Cleveland Clinic) ; Bermel, Robert (Mellen Center, Neurologic Institute, Cleveland Clinic) ; Grossman, Cynthia I. (Biogen, Cambridge) ; Hersh, Carrie (Cleveland Clinic (Las Vegas)) ; Hyland, Megan. (University of Rochester. Department of Neurology) ; Mowry, Ellen M. (Johns Hopkins University. Department of Neurology) ; Naismith, Robert (Washington University in St. Louis. Department of Neurology) ; Naylor, Maria L. (Biogen, Cambridge) ; Nicholas, Jacqueline (OhioHealth Multiple Sclerosis Center) ; Rajbhandar, Rajani (Biogen, Cambridge) ; Singh, Carol M. (Biogen, Cambridge) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Ziemssen, Tjalf (University Clinic Carl-Gustav Carus. Department of Neurology) ; Williams, James R. (Biogen, Cambridge) ; Montalban, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina)
The impact of multiple sclerosis (MS) disease-modifying therapies (DMTs) on SARS-CoV-2 vaccination response is uncertain. Post-SARS-CoV-2 vaccination blood samples across multiple DMTs were tested for SARS-CoV-2 immunoglobulin G (IgG) response. [...]
2022 - 10.1177/13524585211061343
Multiple sclerosis, Vol. 28 Num. 7 (january 2022) , p. 1131-1137  
Registre complet - Creative Commons
3.
14 p, 2.2 MB Associations of with clinico-radiological measures in a large population / Sotirchos, Elias S. (Johns Hopkins University School of Medicine) ; Fitzgerald, Kathryn (Johns Hopkins University School of Medicine) ; Singh, Carol (Biogen) ; Smith, Matthew D. (Johns Hopkins University School of Medicine) ; Reyes-Mantilla, Maria (Johns Hopkins University School of Medicine) ; Hersh, Carrie (Cleveland Clinic) ; Hyland, Megan H. (University of Rochester Medical Center) ; Canissario, Ryan (University of Rochester Medical Center) ; Simmons, Sarah B. (Mellen Center, Neurological Institute, Cleveland Clinic) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Naismith, Robert (Washington University in St. Louis) ; Qiao, Min (Washington University in St. Louis) ; Krupp, Lauren B. (New York University) ; Nicholas, Jacqueline A. (Riverside Methodist Hospital) ; Akgün, Katja (University Clinic Carl-Gustav Carus) ; Ziemssen, Tjalf (University Clinic Carl-Gustav Carus) ; Rudick, Richard ((formerly) Biogen) ; Fisher, Elizabeth (Biogen) ; Bermel, Robert (Mellen Center, Neurological Institute, Cleveland Clinic) ; Mowry, Ellen (Johns Hopkins University School of Medicine) ; Calabresi, Peter A. (Johns Hopkins University School of Medicine) ; Universitat Autònoma de Barcelona
Evaluation of serum neurofilament light chain (sNfL), measured using high-throughput assays on widely accessible platforms in large, real-world MS populations, is a critical step for sNfL to be utilized in clinical practice. [...]
2022 - 10.1002/acn3.51704
Annals of Clinical and Translational Neurology, Vol. 10 (november 2022) , p. 84-97  
Registre complet - Creative Commons
4.
15 p, 865.1 KB Harnessing Real-World Data to Inform Decision-Making : Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) / Mowry, Ellen M. (Johns Hopkins University) ; Bermel, Robert (Cleveland Clinic) ; Williams, James R. (Biogen) ; Benzinger, Tammie L. S. (Washington University in St. Louis) ; de Moor, Carl (Biogen) ; Fisher, Elizabeth (Biogen) ; Hersh, Carrie M. (Cleveland Clinic Lou Ruvo Center for Brain Health) ; Hyland, Megan H. (University of Rochester Medical Center) ; Izbudak, Izlem (Johns Hopkins University) ; Jones, Stephen E. (Cleveland Clinic) ; Kieseier, Bernd C. (Biogen) ; Kitzler, Hagen H. (University Clinic Carl Gustav Carus, TU Dresden) ; Krupp, Lauren (New York University) ; Lui, Yvonne W. (New York University) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Naismith, Robert T. (Washington University in St. Louis) ; Nicholas, Jacqueline A. (OhioHealth) ; Pellegrini, Fabio (Biogen) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Schulze, Maximilian (University Hospital of Giessen and Marburg (Alemanya)) ; Tackenberg, Björn (University Hospital of Giessen and Marburg (Alemanya)) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Tivarus, Madalina E. (University of Rochester Medical Center) ; Ziemssen, Tjalf (Center of Clinical Neuroscience, University Clinic Carl Gustav Carus, TU Dresden) ; Rudick, Richard A. (Biogen) ; Universitat Autònoma de Barcelona
Background: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) is the first example of a learning health system in multiple sclerosis (MS). This paper describes the initial implementation of MS PATHS and initial patient characteristics. [...]
2020 - 10.3389/fneur.2020.00632
Frontiers in neurology, Vol. 11 (august 2020)  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem